...
首页> 外文期刊>Physical medicine and rehabilitation clinics of North America >Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations.
【24h】

Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations.

机译:阿片类药物在治疗慢性疼痛中的作用:法律框架以及治疗适应症和局限性。

获取原文
获取原文并翻译 | 示例

摘要

The most important message that physicians must communicate to persons with chronic pain is that, currently, no medication exists that will take away more than 30% of the pain they experience. Chronic pain is a chronic disease and, like diabetes or hypertension, requires chronic concessions and lifestyle modifications. In controlled trials of short duration and small sample size with highly selected patients, patients sustaining moderate-to-severe pain still experience moderate pain even on opioid medication. Adverse drug effects are predictable and common, and, in fact, long-term compliance with opioids is low owing to side effects. Screening for substance abuse by history taking, observing behavior, obtaining old medical records,and using UDS in patients before initiating opioid therapy is important to identify patients with comorbid addictive disease who require coincident or antecedent treatment. Familiarity with federal and state controlled substance legislation and state health care provider and pain treatment acts is a mundane but essential educational endeavor for all physicians prescribing opioids. If physicians educate their patients with chronic pain about the limited efficacy of the medications, patients' expectations for drug treatment can be more realistic.
机译:医生必须与患有慢性疼痛的人交流的最重要的信息是,目前尚不存在能够消除他们所经历的疼痛超过30%的药物。慢性疼痛是一种慢性疾病,与糖尿病或高血压一样,需要长期的让步和生活方式的改变。在短期和小样本量的高度对照患者的对照试验中,承受中度至重度疼痛的患者即使使用阿片类药物也仍然会出现中度疼痛。药物不良反应是可预见的并且是常见的,事实上,由于副作用,长期与阿片类药物的依从性很低。在开始阿片类药物治疗之前,通过历史记录,观察行为,获取旧的医疗记录以及在患者中使用UDS筛查药物滥用对于识别需要同时或先前治疗的合并性成瘾性疾病患者非常重要。对于所有开处方阿片类药物的医生来说,熟悉联邦和州管制药物法规以及州医疗保健提供者和疼痛治疗法案是一项平凡但必不可少的教育工作。如果医生对患有慢性疼痛的患者进行有限的药物治疗教育,那么患者对药物治疗的期望可能会更加现实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号